Fractyl Health (GUTS) Competitors $1.84 -0.10 (-5.15%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$1.86 +0.02 (+1.36%) As of 01/31/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GUTS vs. SMTI, DRTS, ELMD, INGN, NYXH, ZYXI, CATX, LUNG, RCEL, and AVRShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Sanara MedTech (SMTI), Alpha Tau Medical (DRTS), Electromed (ELMD), Inogen (INGN), Nyxoah (NYXH), Zynex (ZYXI), Perspective Therapeutics (CATX), Pulmonx (LUNG), AVITA Medical (RCEL), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Sanara MedTech Alpha Tau Medical Electromed Inogen Nyxoah Zynex Perspective Therapeutics Pulmonx AVITA Medical Anteris Technologies Global Fractyl Health (NASDAQ:GUTS) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk, institutional ownership and community ranking. Do institutionals & insiders hold more shares of GUTS or SMTI? 8.1% of Sanara MedTech shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is GUTS or SMTI more profitable? Sanara MedTech has a net margin of -10.71% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% Sanara MedTech -10.71%-19.86%-10.91% Do analysts rate GUTS or SMTI? Fractyl Health presently has a consensus price target of $22.00, indicating a potential upside of 1,095.65%. Sanara MedTech has a consensus price target of $47.00, indicating a potential upside of 29.37%. Given Fractyl Health's higher probable upside, analysts clearly believe Fractyl Health is more favorable than Sanara MedTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in GUTS or SMTI? Sanara MedTech received 18 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 58.33% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes3100.00% Underperform VotesNo VotesSanara MedTechOutperform Votes2158.33% Underperform Votes1541.67% Which has preferable earnings and valuation, GUTS or SMTI? Sanara MedTech has higher revenue and earnings than Fractyl Health. Sanara MedTech is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$120K737.53-$77.09M-$12.19-0.15Sanara MedTech$64.99M4.89-$4.30M-$0.99-36.70 Does the media prefer GUTS or SMTI? In the previous week, Sanara MedTech had 7 more articles in the media than Fractyl Health. MarketBeat recorded 12 mentions for Sanara MedTech and 5 mentions for Fractyl Health. Sanara MedTech's average media sentiment score of 0.95 beat Fractyl Health's score of 0.20 indicating that Sanara MedTech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fractyl Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sanara MedTech 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySanara MedTech beats Fractyl Health on 10 of the 15 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$97.16M$4.87B$5.58B$9.12BDividend YieldN/A51.39%5.31%3.99%P/E RatioN/A14.7958.9914.21Price / Sales737.5355.771,258.0383.19Price / CashN/A52.1145.9637.70Price / BookN/A8.145.124.71Net Income-$77.09M$89.07M$111.17M$224.24M7 Day Performance-11.96%-2.28%2.37%-0.17%1 Month Performance-10.68%8.36%3.19%0.60%1 Year PerformanceN/A29.54%24.69%20.43% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health1.7804 of 5 stars$1.84-5.2%$22.00+1,095.7%N/A$97.16M$120,000.000.00102Short Interest ↑News CoveragePositive NewsHigh Trading VolumeSMTISanara MedTech2.8091 of 5 stars$36.69-1.2%$47.00+28.1%+7.5%$320.67M$64.99M-37.0660DRTSAlpha Tau Medical2.4196 of 5 stars$4.20+4.2%$8.00+90.5%+11.4%$293.68MN/A-9.7780Short Interest ↑Negative NewsHigh Trading VolumeELMDElectromedN/A$33.14-1.0%N/A+242.3%$280.36M$54.72M46.03160INGNInogen2.8479 of 5 stars$11.48+0.3%$7.00-39.0%+64.3%$273.45M$315.66M-5.101,030Analyst ForecastShort Interest ↓News CoverageHigh Trading VolumeNYXHNyxoah3.0041 of 5 stars$10.83+0.2%$17.00+57.0%-0.2%$270.10M$5.08M-5.79110Positive NewsGap UpZYXIZynex3.8115 of 5 stars$8.19-2.0%$14.00+70.9%-33.8%$260.85M$184.32M54.601,100Positive NewsCATXPerspective Therapeutics2.0812 of 5 stars$3.83-4.5%$15.14+295.4%N/A$258.87M$1.43M0.0070LUNGPulmonx1.9224 of 5 stars$6.29+2.9%$12.75+102.7%-57.2%$248.39M$68.68M-4.28250Short Interest ↑RCELAVITA Medical1.7224 of 5 stars$9.32flat$18.00+93.1%-45.7%$244.37M$50.14M-4.18130Short Interest ↑AVRAnteris Technologies GlobalN/A$6.00+0.2%$16.50+175.0%N/A$215.64MN/A0.00138Positive News Related Companies and Tools Related Companies Sanara MedTech Alternatives Alpha Tau Medical Alternatives Electromed Alternatives Inogen Alternatives Nyxoah Alternatives Zynex Alternatives Perspective Therapeutics Alternatives Pulmonx Alternatives AVITA Medical Alternatives Anteris Technologies Global Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GUTS) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
